Practical guidelines for physicians in the management of febrile seizures

Brain Dev. Nov-Dec 1996;18(6):479-84. doi: 10.1016/s0387-7604(96)00066-6.

Abstract

Recent studies have shown that adequate medication can prevent the recurrence of febrile seizures (FS). It has also been clarified that the vast majority of, though not all, FS patients follow a benign course. Then, questions arise as to whether or not FS should be prevented, particularly in light of the risks of side effects from drugs. Which kinds of FS can be prevented, if necessary? The guidelines presented here are aimed primarily at helping general practitioners in considering how to manage FS most appropriately. The guidelines stress that judgements should be individualized, while referring to a few specific 'warning factors'. The guidelines follow a 'laissez-faire' principle for the majority of FS cases, whereas intermittent therapy with diazepam and continuous medication with either phenobarbital or valproate are indicated in other limited cases meeting respective definite criteria.

Publication types

  • Consensus Development Conference
  • Review

MeSH terms

  • Humans
  • Practice Guidelines as Topic
  • Seizures, Febrile / diagnosis
  • Seizures, Febrile / prevention & control
  • Seizures, Febrile / therapy*